Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Naoto Uemura"'
Autor:
Akira Tanaka, Naoto Uemura, Kanako Kuniyeda, Haruhi Ando, Toshinori Higashi, Hiroshi Nagabukuro
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1898-1910 (2023)
Abstract ART‐001 is an orally available selective PI3Kα inhibitor currently being developed for the treatment of slow‐flow vascular malformations (SFVMs). ART‐001 used to be developed for advanced solid tumors, but was suspended largely due to
Externí odkaz:
https://doaj.org/article/8ac6e765d6004e4698082031597390ac
Autor:
Keiko Matsuura, Satoshi Kushio, Hiromitsu Imai, Hideo Kudo, Hirokazu Wakuda, Naoyuki Otani, Masae Kuranari, Ai Sekiguchi, Tetsuji Ohyama, Naoto Uemura
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 4, Pp 686-693 (2023)
Abstract Sustained exposure to acetaldehyde, the major metabolite of ethanol, may influence psychomotor performance even after the breath ethanol level significantly drops several hours following ethanol consumption. We examined the relationship betw
Externí odkaz:
https://doaj.org/article/04b088cba7a748948c9c5f1ec3fd8bec
Autor:
Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa, Ikuo Aoki, Hiroyuki Yoshitsugu, Hiroyuki Ugai, Naoyoshi Yatsuzuka, Yoshiyuki Tanaka, Kenichi Furihata, Brian M. Maas, Prachi K. Wickremasingha, Kelly E. Duncan, Marian Iwamoto, Selwyn A. Stoch, Naoto Uemura
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 11, Pp 2697-2708 (2022)
Abstract Molnupiravir (MK‐4482) is an oral prodrug of the antiviral ribonucleoside analog, N‐hydroxycytidine (NHC), which has activity against RNA viruses, including severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2). We conducted
Externí odkaz:
https://doaj.org/article/6adea459e92c4204accad4b1f01dc2eb
Autor:
Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, Kenji Tsushima, Masaharu Sinkai, Naoyuki Komura, Kazuo Yoshida, Yasutoshi Kido, Hiroshi Kakeya, Naoto Uemura, Junichi Kadota
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background In vitro drug screening studies have indicated that camostat mesilate (FOY-305) may prevent SARS-CoV-2 infection into human airway epithelial cells. This study was conducted to investigate whether camostat mesilate is an effective
Externí odkaz:
https://doaj.org/article/c2b551bd5bc24002b5e386c1c609d224
Autor:
Yuji Orito, Naoyuki Otani, Yuki Matsumoto, Katsukuni Fujimoto, Nobuyuki Oshima, Brian M. Maas, Luzelena Caro, Antonios O. Aliprantis, Kara S. Cox, Osamu Tokumaru, Masaaki Kodama, Hideo Kudo, Hiromitsu Imai, Naoto Uemura
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 7, Pp 1753-1763 (2022)
Abstract Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection among all infants worldwide and remains a significant cause of morbidity and mortality. To address this unmet medical need, MK‐1654, a half‐life
Externí odkaz:
https://doaj.org/article/e40accb32f454104982f83fe7c931136
Autor:
Junsaku Kitagawa, Hayato Arai, Hiroyuki Iida, Jiro Mukai, Kenji Furukawa, Seitaro Ohtsu, Susumu Nakade, Tomohiro Hikima, Miwa Haranaka, Naoto Uemura
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1967-1976 (2021)
Abstract Camostat mesylate, an oral serine protease inhibitor, is used to treat chronic pancreatitis and reflux esophagitis. Recently, camostat mesylate and its active metabolite 4‐(4‐guanidinobenzoyloxy)phenylacetic acid (GBPA) were reported to
Externí odkaz:
https://doaj.org/article/f1376106677341e6ac6e9becf4c1fc0c
Autor:
Keiko Ueda, Naoto Uemura, Kotone Matsuyama, Yuji Nishizaki, Nanae Tanemura, Kento Asano, Yuki Otsuka, Naotake Yanagisawa, Toshiaki Otsuka, Shinji Yasuno, Rieko Ueda, Yumiko Seo, Hironori Nakagami, Shoji Sanada
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 2, Pp 745-755 (2021)
The purpose of this study was to conduct a factual survey to evaluate the type of clinical research support offered by service providers (supporters) in Japanese academic research organizations (AROs). From September to October 2018, we conducted an
Externí odkaz:
https://doaj.org/article/738b3cbad2a54d29aba3ee3b18f42d56
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 4, Pp 700-706 (2020)
Japan’s Advanced Medical Care Program (AMCP) seeks to facilitate patient access to promising healthcare technologies through National Health Insurance (NHI) coverage. This study aimed to examine AMCP’s contribution to the accelerated introduction
Externí odkaz:
https://doaj.org/article/6a3b96bf4dc8442b8a8c3853c54847d4
Autor:
Taku Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, Katsuya Shiraki, Yuji Hirai, Yoshiko Kichikawa, Kenji Tsushima, Masaharu Shinkai, Naoyuki Komura, Kazuo Yoshida, Yasutoshi Kido, Hiroshi Kakeya, Naoto Uemura, Junichi Kadota
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/469116f7183f4f6a8133c08824a1b724
Autor:
Naoyuki Otani, Hirokazu Wakuda, Hiromitsu Imai, Masae Kuranari, Yasuyuki Ishii, Yuko Ito, Akihiro Okubo, Osamu Ogawa, Kenji Takeda, Tetsuji Ohyama, Tomoko Hasunuma, Naoto Uemura
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 5, Pp 513-518 (2019)
This study evaluated the utility of combination of digoxin (0.25 mg) and rosuvastatin (5 mg) as a new transporter (P‐glycoprotein/breast cancer resistance protein/organic anion‐transporting polypeptide (OATP)1B1/OATP1B3) probe cocktail (Oita comb
Externí odkaz:
https://doaj.org/article/fae327b93c584f7180015f4fb07afd0b